The first goal of this study is to see how brain activity changes in people with fibromyalgia after they get a treatment called rTMS (repetitive transcranial magnetic stimulation). Researchers are looking at how the parts of the brain that control movement (called motor cortices) respond to this treatment.
The second goal is to find out if the changes in brain activity are different between the right and left sides of the brain, depending on which side gets the treatment.
Female aged 18 to 65, right-handed, with no racial/ethnic restrictions.
A diagnosis of fibromyalgia by a qualified physician according to the American College of Rheumatology 2016 criteria
Must have a history of fibromyalgia pain for a duration ≥ 3 months, as it is included in the diagnostic criteria.
Must have pain intensity equal or greater than 4/10 on the numerical rating scale (NRS) at enrollment.
Inability to provide informed consent.
Age outside the studied range (i.e., < 18, > 65).
Patients planning to change their medications during trial.
Participants who are currently receiving other alternative therapies during trial (e.g., physiotherapy, acupuncture).